netFormulary
 Report : A-Z HCD items in Formulary 13/04/2021 13:45:15
[Back]
 
Section Status HCD Name
01.05.03 Formulary Cancer Drugs Fund Adalimumab Amgevita
13.05.03 Formulary Cancer Drugs Fund Adalimumab Amgevita
13.05.03 Formulary Cancer Drugs Fund Adalimumab Amgevita
08.02 Restricted Use Cancer Drugs Fund Apremilast  Otezla
13.05.03 Formulary Cancer Drugs Fund Brodalumab Kyntheum
13.05.03 Formulary Cancer Drugs Fund Certolizumab  Cimzia
13.04 Formulary Cancer Drugs Fund Clobetasol Propionate (with antimicrobials) Dermovate-NN
13.05.03 Formulary Cancer Drugs Fund Dimethyl fumarate Skilarence
03.07 Formulary Cancer Drugs Fund Dornase Alfa Pulmozyme
13.05.03 Formulary Cancer Drugs Fund Dupilumab Dupixent
08.01.05 Formulary Cancer Drugs Fund Encorafenib Braftovi®
08.01.05 Formulary Cancer Drugs Fund Encorafenib Braftovi®
02.12 Restricted Use Cancer Drugs Fund Evolocumab Repatha
04.07.04.02 Formulary Cancer Drugs Fund Fremanezumab Ajovy
04.07.04.02 Formulary Cancer Drugs Fund Galcanezumab Emgality
01.05.03 Formulary Cancer Drugs Fund Golimumab Simponi
13.05.03 Formulary Cancer Drugs Fund Golimumab Simponi
13.05.03 Formulary Cancer Drugs Fund Guselkumab Tremfya
01.05.03 Formulary Cancer Drugs Fund Infliximab Remsima
13.05.03 Formulary Cancer Drugs Fund Infliximab Remsima
13.05.03 Formulary Cancer Drugs Fund Ixekizumab Taltz
08.01 Restricted Use Cancer Drugs Fund Nivolumab Opdivo
13.05.03 Formulary Cancer Drugs Fund Omalizumab Xolair
13.05.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx
05.03.03.02 Formulary Cancer Drugs Fund Simeprevir Olysio
13.05.03 Formulary Cancer Drugs Fund Tildrakizumab Ilumetri
01.05.03 Formulary Cancer Drugs Fund Tofacitinib Xeljanz
10.01.03 Formulary Cancer Drugs Fund Upadacitinib  Rinvoq
01.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara
13.05.03 Restricted Use Cancer Drugs Fund Ustekinumab Stelara
01.05.03 Formulary Cancer Drugs Fund Vedolizumab Entyvio
Bradford Teaching Hospitals